Kitang, James .
HRN: 11-71-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/02/2024
07/09/2024
IV
600mg
Every 6 Hours
DM Foot
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes